内皮原生细胞和慢性阻塞性肺病:从基础研究到临床应用
Xue He1,2, Huihui Zeng3,4,5,6, Yan Chen7,8,9,10
1Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha 410011. hexuehuxi@csu.edu.cn.
概括
内皮原生细胞 (EPC) 对于慢性阻塞性肺病 (COPD) 的血管修复至关重要. 降低COPD患者的EPC与疾病严重程度相关,环境因素进一步损害EPC功能,建议EPC作为治疗点.
科学领域:
- 肺部医学 肺部医学
- 血管生物学 血管生物学
- 再生医学是一种再生医学.
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及持续的空气流量限制和血管内皮功能障碍.
- 内皮原生细胞 (EPC) 对于血管修复和再生至关重要,在COPD的发病过程中起着关键作用.
研究的目的:
- 调查EPCs在COPD病变发生中的作用.
- 探索环境因素对COPD中EPCs的影响.
- 评估EPC作为COPD潜在的治疗点.
主要方法:
- 对COPD患者循环EPC数量和功能的分析.
- 在EPC上的环境因素 (吸烟,PM2.5) 的评估.
- 对调节EPCs的分子通路 (VEGF/VEGFR,CXCL12/CXCR4) 的审查.
- 在动物模型中检查EPC移植疗效.
主要成果:
- 慢性肺炎患者的循环EPC数量显著减少,功能受损.
- 减少EPC与COPD的严重程度,肺功能下降,恶化和并发症有关.
- 吸烟和PM2.5等环境因素进一步降低了EPC的数量和功能.
- 动物研究表明,EPC移植后肺功能和病理状况得到改善.
结论:
- EPC功能障碍是COPD的关键病原机制.
- 准EPC具有前景,作为COPD的新疗法策略.
- 对EPC机制和临床应用的进一步研究可能有助于推进COPD治疗.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:20COPD: Pathogenesis and Clinical Features
200
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
200
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K